Schedule 13D ownership disclosure
AV Therapeutics, Inc.
Security class unavailable · CUSIP: 002427102
Event date: 2014-07-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001185185-14-001813
- Form type
- SC 13D
- Filer
- AV Therapeutics, Inc.
- CIK
- CIK 1537293
- Filed
- Jul 16, 2014
- Reporting period
- Jul 14, 2014
- Description
- Schedule 13D beneficial ownership